$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Type 2 diabetes mellitus (T2DM) is a global health crisis. T2DM is characterized by insulin signaling impairment and chronic inflammation in peripheral tissues. The hypothalamus is the control center which regulates the body's energy homeostasis, appetite, and circadian rhythms. Most importantly, the hypothalamus also mediates insulin signal responsiveness to regulate systemic metabolism1,2,3,4,5. Disrupting the hypothalamic insulin signaling pathway could induce insulin resistance6,7. The hypothalamus coordinates cellular energy status and secretion of hormones, such as insulin and adipokines (e.g., leptin) from the peripheral tissues, to regulate systemic glucose metabolism, insulin responsiveness, and food intake. Insulin binding to the insulin receptor activates insulin receptor substrate (IRS) proteins, which then activate insulin downstream signaling molecules, such as PI3K (phosphatidylinositol 3-kinase) and AKT (protein kinase B (PKB/AKT)), to induce GLUT4 membrane translocation. Neurons are not the major target for glucose uptake in response to insulin; however, significant levels of GLUT4 expression have been identified in the hypothalamic arcuate nucleus (ARC) region. Therefore, the regulation of GLUT4 in hypothalamic neurons may play an important role in insulin signaling in the brain-peripheral axis.
Many studies have suggested that chronic inflammation and inflammatory chemokines in hypothalamus also play an important role in the development of diabetes and obesity, and inhibition of hypothalamic inflammation can reverse diet-induced insulin resistance8,9,10. Moreover, chemokine-CCL5 (C-C motif ligand 5, also known as RANTES, Regulated-on-Activation-Normal-T-cell-Expressed-and-Secreted) and its receptor CCR5 levels also correlate with the development of T2DM11,12. The roles of CCL5 and CCR5 in insulin function and glucose metabolism remain unclear. One study reported that CCR5 deficiency protected mice from obesity-induced inflammation, macrophage recruitment, and insulin resistance11; in contrast, another study reported that CCR5 deficiency impairs systemic glucose tolerance, as well as adipocyte and muscle insulin signaling12. CCL5 is found to increase glucose uptake in T-cells and to reduce food intake through its action on the hypothalamus13,14, however, both the mechanism of action and the receptors involved are yet to be identified.
It is difficult to study the cellular mechanisms underlying the effect of peripheral tissue inflammation on insulin functioning in hypothalamic neurons. This is due to cellular heterogeneity and neuron circuit feedback regulations. For this reason, an in vitro cell culture model provides a clean model to investigate the effects of the chemokine on hypothalamic insulin signal regulation. Although there are many established immortalized hypothalamic neuronal cell lines for research use, these cell lines expressed different markers, and therefore, represent different types of hypothalamic neurons15. Even though primary hypothalamic cultures can be difficult to maintain, they can provide the most realistic response of hypothalamic neurons upon insulin stimulation, and can also avoid the potential unknown effects which come into play when maintaining cells long-term in culture medium with artificial growth factors.
Herein, we utilize primary hypothalamic neurons from both C57BL/6 wildtype (WT) mouse and CCR5 knockout (CCR5-/-) mouse, and transfect both types of cells with GFP-GLUT4 construct. To investigate the contribution of CCR5 to insulin mediated GLUT4 membrane trafficking, GFP-GLUT4 transfected neurons were treated with insulin or recombinant CCL5. We then characterize the movement of GFP-GLUT4 on the plasma membrane in primary hypothalamic neurons with Deconvolution Microscopy.